tiprankstipranks
Carisma Therapeutics (CARM)
NASDAQ:CARM

Carisma Therapeutics (CARM) Technical Analysis

1,504 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Carisma Therapeutics’s (CARM) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Carisma Therapeutics is a Sell.
Carisma Therapeutics’s (CARM) 20-Day exponential moving average is 1.28, while Carisma Therapeutics’s (CARM) share price is $1.44, making it a Buy.
Carisma Therapeutics’s (CARM) 50-Day exponential moving average is 1.42, while Carisma Therapeutics’s (CARM) share price is $1.44, making it a Buy.

Carisma Therapeutics (CARM) Pivot Points

Jul 03, 2024, 05:39 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.11
1.23
1.45
1.58
1.80
1.92
2.14
Fibonacci
1.23
1.36
1.44
1.58
1.71
1.79
1.92
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Carisma Therapeutics (CARM) Moving Averages

Jul 03, 2024, 05:39 AM
Period
Simple
Exponential
MA5
1.43Buy
1.43Buy
MA10
1.25Buy
1.33Buy
MA20
1.20Buy
1.28Buy
MA50
1.38Buy
1.42Buy
MA100
1.81Sell
1.82Sell
MA200
2.40Sell
2.80Sell
Carisma Therapeutics’s (CARM) 10-Day exponential moving average is 1.33, while Carisma Therapeutics’s (CARM) share price is $1.44, making it a Buy.
Carisma Therapeutics’s (CARM) 100-Day exponential moving average is 1.82, while Carisma Therapeutics’s (CARM) share price is $1.44, making it a Sell.
Carisma Therapeutics’s (CARM) stock price is $1.44 and Carisma Therapeutics’s (CARM) 50-day simple moving average is 1.38, creating a Buy signal.
Carisma Therapeutics’s (CARM) stock price is $1.44 and Carisma Therapeutics’s (CARM) 100-day simple moving average is 1.81, creating a Sell signal.
Carisma Therapeutics’s (CARM) stock price is $1.44 and Carisma Therapeutics’s (CARM) 200-day simple moving average is 2.40, creating a Sell signal.

Carisma Therapeutics (CARM) Technical Indicators

Jul 03, 2024, 05:39 AM
Name
Value
Implied Action
RSI (14)
56.46
Neutral
STOCH (9,6)
60.53
Neutral
STOCHRSI (14)
60.81
Neutral
MACD (12,26)
0.01
Sell
ADX (14)
39.62
Neutral
Williams %R
-50.55
Buy
CCI (14)
168.72
Sell
ATR (14)
0.17
-
Ultimate Oscillator
53.85
Neutral
ROC
16.13
Buy
Carisma Therapeutics’s (CARM) Relative Strength Index (RSI) is 56.46, creating a Neutral signal.
Carisma Therapeutics’s (CARM) Trend Strength Indicator (ADX) is 39.62, creating a Neutral signal.
Carisma Therapeutics’s (CARM) Commodity Channel Index (CCI) is 168.72, creating a Sell signal.
Carisma Therapeutics’s (CARM) Price Rate of Change (ROC) is 16.13, creating a Buy signal.

FAQ

Is CARM a Buy, Hold, or Sell?
Based on CARM’s technical indicators, CARM is a Buy.
    What is CARM’s RSI (14)?
    CARM’s RSI (14) is 56.46, which suggests CARM is a Neutral.
      What is CARM’s MACD?
      CARM’s MACD is 0.01, which suggests CARM is a Sell.
        What is CARM’s 5-day moving average?
        CARM’s 5-day moving average is 1.43, which suggests CARM is a Buy.
          What is CARM’s 20-day moving average?
          CARM 20-day moving average is 1.20, which suggests CARM is a Buy.
            What is CARM’s 50-day moving average?
            CARM’s 50-day moving average is 1.38, which suggests CARM is a Buy.
              What is CARM’s 200-day moving average?
              CARM’s 200-day moving average is 2.40, which suggests CARM is a Sell.
                What is CARM’s Williams % R (14)?
                CARM’s Williams % R (14) is -50.55, which suggests CARM is a Buy.
                  What is CARM’s CCI (14)?
                  CARM’s CCI (14) is 168.72, which suggests CARM is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis